Overview
Remi Favier practices practicing medicine in Paris, France.
Ms. Favier is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Gray Platelet Syndrome, Thrombocytopenia, RUNX1 Familial Platelet Disorder, and MYH9 Related Thrombocytopenia.
She is actively involved in clinical research, co-authoring 75 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Remi Favier
Is Remi Favier a top-rated expert for Gray Platelet Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Remi Favier is classified as an Elite expert for Gray Platelet Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Remi Favier participate in research or clinical trials?
Yes. Remi Favier has published 75 articles and abstracts on conditions like Gray Platelet Syndrome. You can view a list of Remi Favier's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Gray Platelet SyndromeMs. Favier isElite. Learn about Gray Platelet Syndrome.
- Distinguished
- Acquired Amegakaryocytic ThrombocytopeniaMs. Favier isDistinguished. Learn about Acquired Amegakaryocytic Thrombocytopenia.
- MYH9 Related ThrombocytopeniaMs. Favier isDistinguished. Learn about MYH9 Related Thrombocytopenia.
- RUNX1 Familial Platelet DisorderMs. Favier isDistinguished. Learn about RUNX1 Familial Platelet Disorder.
- ThrombocytopeniaMs. Favier isDistinguished. Learn about Thrombocytopenia.
- Advanced
- Bernard-Soulier SyndromeMs. Favier isAdvanced. Learn about Bernard-Soulier Syndrome.
- Blood ClotsMs. Favier isAdvanced. Learn about Blood Clots.
- Platelet Storage Pool DeficiencyMs. Favier isAdvanced. Learn about Platelet Storage Pool Deficiency.
- Experienced
- Acute Myeloid Leukemia (AML)Ms. Favier isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Chronic Graft Versus Host Disease (cGvHD)
- Essential ThrombocythemiaMs. Favier isExperienced. Learn about Essential Thrombocythemia.
- Hearing LossMs. Favier isExperienced. Learn about Hearing Loss.
- Hemophilia AMs. Favier isExperienced. Learn about Hemophilia A.
- Jacobsen SyndromeMs. Favier isExperienced. Learn about Jacobsen Syndrome.
- LeukemiaMs. Favier isExperienced. Learn about Leukemia.
- MyelofibrosisMs. Favier isExperienced. Learn about Myelofibrosis.
- Paris-Trousseau ThrombocytopeniaMs. Favier isExperienced. Learn about Paris-Trousseau Thrombocytopenia.
- SplenomegalyMs. Favier isExperienced. Learn about Splenomegaly.
- Thrombocytopenia-Absent Radius SyndromeMs. Favier isExperienced. Learn about Thrombocytopenia-Absent Radius Syndrome.
- Von Willebrand Disease (VWD)Ms. Favier isExperienced. Learn about Von Willebrand Disease (VWD).